S. 1702119th CongressIn committeeLatest action May 8, 2025Decoded by AI · checked against the record
Official title: Access to Prescription Digital Therapeutics Act of 2025
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
Starting in 2026, Medicare and Medicaid would be required to cover FDA-cleared prescription digital therapeutics like treatment apps.
45-second read · 5 questions answered below
This bill requires Medicare and Medicaid to cover "prescription digital therapeutics" — FDA-cleared software, apps, or devices that prevent, manage, or treat medical conditions primarily through software. Starting January 1, 2026, these products become a covered Medicare benefit, and Medicaid must cover them too. The bill also sets timelines for Medicare to create payment methods and billing codes for these products.
Medicare and Medicaid patients who could be prescribed app-based or software-based treatments, and manufacturers of these digital therapeutics. Doctors and health systems are also affected, since this creates a new billable treatment category.
This establishes a formal, government-reimbursed pathway for software-based treatments, changing how doctors can prescribe and bill for care alongside traditional drugs and devices.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Finance.